2017
DOI: 10.1002/14651858.cd012024.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy

Abstract: Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
14
1
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 40 publications
(19 citation statements)
references
References 121 publications
1
14
1
3
Order By: Relevance
“…Administration of progesterone agents could prevent SPTD, but in multiple pregnancies, it does not appear to be associated with a reduction in the risk of preterm birth . Thus, it is not known whether 17OHP‐C is effective for preventing preterm labor (PTL).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Administration of progesterone agents could prevent SPTD, but in multiple pregnancies, it does not appear to be associated with a reduction in the risk of preterm birth . Thus, it is not known whether 17OHP‐C is effective for preventing preterm labor (PTL).…”
Section: Discussionmentioning
confidence: 99%
“…Administration of progesterone agents could prevent SPTD, 10 but in multiple pregnancies, it does not appear to be associated with a reduction in the risk of preterm birth. 24 Thus, it is not known whether 17OHP-C is effective for preventing preterm labor (PTL). However, 17OHP-C, which might be effective in limited PTL cases with mild sterile intra-amniotic inflammation, 11 was administered prophylactically from 16 weeks.…”
Section: Discussionmentioning
confidence: 99%
“…Остается спорным вопрос и об эффективности и безопасности применения прогестагенов и их аналогов у женщин с многоплодной беременностью, хотя в последнее время появляется все больше данных о возможности снижения частоты преждевременных родов и улучшения перинатальных исходов многоплодной беременности при использовании препаратов прогестерона [25].…”
Section: производные прогестеронаunclassified
“…При этом отсутствовали какие-либо явные групповые различия в неонатальных исходах, кроме искусственной вентиляции легких, потребность в которой была меньше у детей, чьи матери получили вагинальный прогестерон (Ор 0,61; 95 % ДИ 0,48-0,77; младенцы -3134, исследования -5). было отмечено, что у женщин с многоплодной беременностью использование прогестерона (как внутримышечного, так и вагинального), вероятно, не связано со снижением риска преждевременных родов или улучшением исходов для новорожденных [33].…”
Section: производные прогестеронаunclassified
“…In twins, CL has a low sensitivity; hence, women at risk are not being identified [6,7]. Moreover, at present, there is no useful intervention to prevent sPTB in twins, but this could be due to the misidentification of women at risk [8].…”
Section: Introductionmentioning
confidence: 99%